Figure 1.
Number and duration of treatment by patient characteristics. The bars show the median duration of the cetuximab treatment for each subgroup of patients. *P< 0.0001 (the non-paired t-test).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.